BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8532723)

  • 21. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.
    Melnick RL; Huff J
    Toxicol Ind Health; 1993; 9(3):415-38. PubMed ID: 8367884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes.
    Perrone CE; Shao L; Williams GM
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):277-86. PubMed ID: 9653058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
    Cattley RC; DeLuca J; Elcombe C; Fenner-Crisp P; Lake BG; Marsman DS; Pastoor TA; Popp JA; Robinson DE; Schwetz B; Tugwood J; Wahli W
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):47-60. PubMed ID: 9629596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of cell proliferation and cell death by peroxisome proliferators.
    Cattley RC
    Microsc Res Tech; 2003 Jun; 61(2):179-84. PubMed ID: 12740824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferators: paradigms and prospects.
    Gibson GG
    Toxicol Lett; 1993 May; 68(1-2):193-201. PubMed ID: 8390728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferators and receptor-mediated hepatic carcinogenesis.
    Cattley RC
    Toxicol Pathol; 2004; 32 Suppl 2():6-11. PubMed ID: 15503658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
    Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
    Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure.
    Weglarz TC; Sandgren EP
    Carcinogenesis; 2004 Jan; 25(1):107-12. PubMed ID: 14514660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of determined stem-cells in the cellular lineage of hepatocellular carcinoma.
    Sell S
    Int J Dev Biol; 1993 Mar; 37(1):189-201. PubMed ID: 8389577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis.
    Bosgra S; Mennes W; Seinen W
    Toxicology; 2005 Jan; 206(3):309-23. PubMed ID: 15588922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel peroxisome proliferator responsive cDNA isolated from rat hepatocytes as the zinc-finger protein ZFP-37.
    Vanden Heuvel JP; Holden P; Tugwood J; Ingle C; Yen W; Galjart N; Greenlee WF
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):107-18. PubMed ID: 9772206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
    Obourn JD; Frame SR; Bell RH; Longnecker DS; Elliott GS; Cook JC
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):425-36. PubMed ID: 9266817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferation and hepatocarcinogenesis.
    Reddy JK; Rao MS
    IARC Sci Publ; 1992; (116):225-35. PubMed ID: 1428083
    [No Abstract]   [Full Text] [Related]  

  • 37. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation and promotion in the hepatocarcinogenicity of peroxisome proliferating chemicals.
    Cattley RC; Marsman DS; Popp JA
    Prog Clin Biol Res; 1990; 340D():123-32. PubMed ID: 2196574
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemicals, cell proliferation, risk estimation, and multistage carcinogenesis.
    Pitot HC; Dragan YP; Neveu MJ; Rizvi TA; Hully JR; Campbell HA
    Prog Clin Biol Res; 1991; 369():517-32. PubMed ID: 1946543
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemically induced cell proliferation and carcinogenesis: differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat.
    Columbano A; Ledda-Columbano GM; Coni P; Pichiri-Coni G; Curto M; Pani P
    Prog Clin Biol Res; 1991; 369():217-25. PubMed ID: 1946520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.